Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,000
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Repligen Corp. market cap is $10.37B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Repligen Corp. 52 week high is $198.87 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Repligen Corp. 52 week low is $100.99 as of November 18, 2026.
Repligen Corp. stock price today is $171.58.
Repligen Corp. stock price yesterday was $162.18.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Repligen Corp.'s P/E ratio is -774.13.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Repligen Corp. P/B ratio is 4.3956.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Repligen Corp. 50-day moving average is $176.92.